ÂÜÀòÂÒÂ×

Yiannis Monovoukas, Ph.D., MBA, is a member of the Board of Directors of Benefits Science Technologies. He is the former Chairman, President, and CEO, and major shareholder of TEI Biosciences Inc. and TEI Medical Inc., two regenerative medicine companies based on technology generated at MIT focusing on the repair, reinforcement, and regeneration of soft tissues. Both companies were sold to Integra LifeSciences in 2015. Dr. Monovoukas is also the Founder, President, and CEO of Helios Cardiovascular and Helios Biomedical, and the co-Founder, President, and CEO of AuraGen Aesthetics and Quantum Medical Analytics.